Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Adverse Drug Reactions of Different Brands of Ceftazidime Injection

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2001 by National Taiwan University Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00173901
First received: September 12, 2005
Last updated: September 13, 2005
Last verified: January 2001

September 12, 2005
September 13, 2005
March 2001
Not Provided
The adverse drug reactions of ceftazidime
Same as current
Complete list of historical versions of study NCT00173901 on ClinicalTrials.gov Archive Site
The effectiveness of ceftazidime
Same as current
Not Provided
Not Provided
 
Adverse Drug Reactions of Different Brands of Ceftazidime Injection
Adverse Drug Reactions of Different Brands of Ceftazidime Injection

The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.

Ceftazidime is a third generation cephalosporins that should be reserved for severe bacterial infections. Substitution of the brand ceftazidime with a generic ceftazidime raised some concerns.

The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.

Interventional
Phase 4
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Infection
Drug: ceftazidime
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
536
April 2002
Not Provided

Inclusion Criteria:

  • patients in surgical intensive care unit who require ceftazidime treatment

Exclusion Criteria:

  • less than 1 year old
Both
1 Year to 95 Years
No
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
NCT00173901
900104
Not Provided
Not Provided
National Taiwan University Hospital
Not Provided
Study Chair: Shan-Chwen Chang, MD PhD National Taiwan University Hospital
National Taiwan University Hospital
January 2001

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP